Chapter

Company Profile
Beacon Pharmaceuticals Limited is a leading Pharmaceutical Company in Bangladesh in
respect of its high-tech products like an anticancer and cardiovascular portfolio.
Beacon, a public limited company listed with Dhaka and Chittagong Stock Exchange,
was incorporated on 12th September 2001 as a private limited company with the
Registrar of Joint Stock Companies and Firms, Dhaka, Bangladesh under the Companies
Act 1994 and subsequently converted into a Public Limited Company on 2010.

Type Sector Founded

Public Pharmaceuticals & Chemicals 2006

Market Category Headquarters DSE Listing Year

A Motijheel C/A, Dhaka, Bangladesh 2010

No. of Shares Outstanding Authorized Capital Paid-up Capital

231 million BDT 3,000 million BDT 2,310 million

Since its inception, Beacon is relentlessly working with a mission to improve the
quality of human life by providing innovative and reliable pharmaceutical products
through continuous research and development by ensuring stakeholder satisfaction
with the aim to be one of the most value-driven Pharmaceutical Companies in the
Country. Beacon is a very popular name in the Pharmaceuticals Industry of
Bangladesh due to its high-quality products of Anticancer, Cardiovascular,
Gastrointestinal, Antibiotics, Anti-Coagulants, Protein Supplements, Muscle
relaxants, Anti-histamine, Analgesics, NSAIDS, etc.
The Plant is situated at Bhaluka, Mymensingh, Bangladesh on a piece of land of 29
Acres with a covered area of more than 1,50,000 sft. The initial cost of the
project stands at more than US$.50.00 Million. This manufacturing complex of Beacon
has been engineered by European consultants in order to be one of the finest
facilities in the Country. It has been designed to conform to world standards like
US-FDA, UK-MHRA, TGA-Australia, and WHO –cGMP.